Cue Biopharma, Inc. Quarterly Return On Assets in % from Q3 2018 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Cue Biopharma, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2018 to Q3 2024.
  • Cue Biopharma, Inc. Return On Assets for the quarter ending September 30, 2024 was -88.1 %, a 33.7% decline year-over-year.
  • Cue Biopharma, Inc. annual Return On Assets for 2023 was -71.1 %, a 15.1% decline from 2022.
  • Cue Biopharma, Inc. annual Return On Assets for 2022 was -61.8 %, a 19.2% decline from 2021.
  • Cue Biopharma, Inc. annual Return On Assets for 2021 was -51.9 %, a 6.56% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -88.1 -22.2 -33.7% Jul 1, 2024 Sep 30, 2024
Q2 2024 -82.9 -18.5 -28.8% Apr 1, 2024 Jun 30, 2024
Q1 2024 -77.6 -15.5 -25% Jan 1, 2024 Mar 31, 2024
Q4 2023 -71.1 -9.33 -15.1% Oct 1, 2023 Dec 31, 2023
Q3 2023 -65.9 -10 -18% Jul 1, 2023 Sep 30, 2023
Q2 2023 -64.3 -6.47 -11.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 -62.1 -8.51 -15.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 -61.8 -9.96 -19.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 -55.9 -3.3 -6.28% Jul 1, 2022 Sep 30, 2022
Q2 2022 -57.9 -12.2 -26.6% Apr 1, 2022 Jun 30, 2022
Q1 2022 -53.6 -8.7 -19.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 -51.9 -3.19 -6.56% Oct 1, 2021 Dec 31, 2021
Q3 2021 -52.6 -2.47 -4.93% Jul 1, 2021 Sep 30, 2021
Q2 2021 -45.7 +11.1 +19.5% Apr 1, 2021 Jun 30, 2021
Q1 2021 -44.9 +24.9 +35.7% Jan 1, 2021 Mar 31, 2021
Q4 2020 -48.7 +23.4 +32.5% Oct 1, 2020 Dec 31, 2020
Q3 2020 -50.1 +38.6 +43.5% Jul 1, 2020 Sep 30, 2020
Q2 2020 -56.8 +44.9 +44.2% Apr 1, 2020 Jun 30, 2020
Q1 2020 -69.8 +21 +23.1% Jan 1, 2020 Mar 31, 2020
Q4 2019 -72 +5 +6.49% Oct 1, 2019 Dec 31, 2019
Q3 2019 -88.7 -21.2 -31.4% Jul 1, 2019 Sep 30, 2019
Q2 2019 -102 Apr 1, 2019 Jun 30, 2019
Q1 2019 -90.8 Jan 1, 2019 Mar 31, 2019
Q4 2018 -77 Oct 1, 2018 Dec 31, 2018
Q3 2018 -67.5 Jul 1, 2018 Sep 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.